Marshall Wace, LLP Semler Scientific, Inc. Transaction History

Marshall Wace, LLP

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$28.42 - $51.54 $669,489 - $1.21 Million	-23,557 Reduced 69.98%	10,107 $295,000
Q4 2023 Feb 14, 2024	SELL	$25.66 - $46.29 $377,869 - $681,666	-14,726 Reduced 30.43%	33,664 $1.49 Million
Q3 2023 Nov 14, 2023	BUY	$23.15 - $28.54 $385,401 - $475,133	16,648 Added 52.45%	48,390 $1.23 Million
Q2 2023 Aug 14, 2023	SELL	$22.5 - $30.58 $32,512 - $44,188	-1,445 Reduced 4.35%	31,742 $832,000
Q1 2023 May 15, 2023	BUY	$19.28 - $41.74 $639,845 - $1.39 Million	33,187 New	33,187 $889,000
Q2 2022 Aug 15, 2022	SELL	$27.86 - $50.32 $287,208 - $518,748	-10,309 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$42.24 - $93.25 $315,617 - $696,764	7,472 Added 263.38%	10,309 $512,000
Q4 2021 Feb 14, 2022	BUY	$89.61 - $149.99 $254,223 - $425,521	2,837 New	2,837 $260,000

3.27M

Ticker SMLR
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 6,800,580
Market Cap $162M
Description
Semler Scientific, Inc. provides technology solutions to improve the clinical effectiveness and efficiency of healthcare providers in the United States. The company's products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient's va...

Get notified when there are updates to the investment portfolio of Marshall Wace, LLP, based on Form 13F filings with the SEC.

Stay updated on Marshall Wace, LLP with notifications on news.